# NLRC5 Regulates Enterovirus 71 Infection Through an IFN-β-Dependent Pathway

**Authors:** Wei Fang, Binbin Zhu, Tan Ge, Xuejuan Liu, Bao Li, Baojing Lu

PMC · DOI: 10.3390/v18020156 · Viruses · 2026-01-23

## TL;DR

This study shows how NLRC5 helps control Enterovirus 71 infection by regulating immune responses and limiting viral replication.

## Contribution

The study reveals a dual role of NLRC5 in suppressing EV71 replication and modulating immune responses via an IFN-β-dependent pathway.

## Key findings

- EV71 infection increases NLRC5 expression through the RIG-I-IRF3-mediated IFN-β pathway, promoting MHC-I molecule expression.
- NLRC5 suppresses EV71 replication and limits inflammation by downregulating IFN-β pathway mediators and binding to the viral genome.
- EV71 activates the NLRC5-dependent MHC-I response in an IFN-β-dependent manner.

## Abstract

During viral infection, NLR family CARD domain-containing protein 5 (NLRC5) participates in innate immunity through multiple mechanisms. These include regulating type I interferon and related immune factor expression, as well as modulating immune cell functions, such as cytotoxic T lymphocytes (CTLs) and macrophages, thereby promoting antiviral defence and maintaining immune homeostasis. Our study demonstrates that (1) Enterovirus 71 (EV71) infection upregulates NLRC5 expression through the RIG-I-IRF3-mediated IFN-β pathway, which in turn promotes MHC-I molecule expression and (2) NLRC5 suppresses EV71 replication and simultaneously restrains excessive inflammatory responses by fine-tuning IFN-β production through a negative feedback loop. This loop operates via two distinct mechanisms, namely, direct downregulation of key IFN-β pathway mediators (e.g., RIG-I and IRF3) and binding to the 5′UTR of the EV71 genome to inhibit viral replication, thereby indirectly dampening the IFN-β signal. Furthermore, we show that EV71 activates the NLRC5-dependent MHC-I response in an IFN-β-dependent manner. Collectively, these results elucidate the dual role of NLRC5 during EV71 infection, offering novel insights into viral pathogenesis and highlighting potential targets for antiviral drug development.

## Linked entities

- **Genes:** NLRC5 (NLR family CARD domain containing 5) [NCBI Gene 84166], RIGI (RNA sensor RIG-I) [NCBI Gene 23586], IRF3 (interferon regulatory factor 3) [NCBI Gene 3661], MHC-I (BOLA class I histocompatibility antigen, alpha chain BL3-7) [NCBI Gene 100009719]
- **Proteins:** IFNB1 (interferon beta 1)

## Full-text entities

- **Genes:** STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, MAVS (mitochondrial antiviral signaling protein) [NCBI Gene 57506] {aka CARDIF, IPS-1, IPS1, VISA}, NLRC5 (NLR family CARD domain containing 5) [NCBI Gene 84166] {aka CLR16.1, NOD27, NOD4}, RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, NLRC5 [NCBI Gene 103233049], DHX58 (DExH-box helicase 58) [NCBI Gene 79132] {aka D11LGP2, D11lgp2e, LGP2, RLR-3}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, CALCOCO2 (calcium binding and coiled-coil domain 2) [NCBI Gene 10241] {aka NDP52}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684] {aka CD317, HM1.24, TETHERIN}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** HFMD (MESH:D006232), RD (MESH:D000077733), dengue virus infection (MESH:D003715), maculopapular rashes (MESH:D005076), central nervous system (CNS) complications (MESH:D002493), NLR (MESH:D020191), neurogenic pulmonary edema (MESH:D011654), congenital malformations (OMIM:163000), painful (MESH:D010146), influenza infection (MESH:D007251), inflammation (MESH:D007249), EV71 Infection (MESH:D004769), injury to (MESH:D014947), infectious disease (MESH:D003141), ulcers (MESH:D014456), COVID-19 (MESH:D000086382), brainstem encephalitis (MESH:D004660), IAV infection (MESH:D007239), encephalomyelitis (MESH:D004679), viral (MESH:D014777), deaths (MESH:D003643)
- **Chemicals:** SDS (MESH:D012967), Trizol (MESH:C411644), polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), Poly (I:C) (MESH:D011070), NaCl (MESH:D012965), DAPI (MESH:C007293), formalin (MESH:D005557), PVDF (MESH:C024865), PBS (MESH:D007854), paraformaldehyde (MESH:C003043), CO2 (MESH:D002245), HE (MESH:D006371), DMEM (-)
- **Species:** Enterovirus A71 (no rank) [taxon 39054], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Porcine deltacoronavirus (no rank) [taxon 1586324], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814]
- **Mutations:** P0013D
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), RD — Homo sapiens (Human), Embryonal rhabdomyosarcoma, Cancer cell line (CVCL_1649), Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945238/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945238/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945238/full.md

---
Source: https://tomesphere.com/paper/PMC12945238